Clinical Trial Update: Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on HSV-2 suppression to reduce HIV transmission in individuals with HIV infection and genital herpes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes
• HIV Infection
• Sexually Transmitted Diseases

Snippet

Sponsor: University of Washington | Conditions: HIV Infection, Herpes Simplex, Genital | Phase 3 | Status: COMPLETED